Results 141 to 150 of about 24,353 (179)

A phase 3, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of vosoritide in children with hypochondroplasia: CANOPY HCH-3 study design. [PDF]

Ther Adv Endocrinol Metab
Dauber A, Savarirayan R, Carroll R, Cheung M, Cormier-Daire V, Maghnie M, Namba N, Semler O, Ghani S, Sabir I, Bassi R.   +10 more
europepmc   +1 more source

Light-Inducible Activation of FGFR3 Facilitates Chondrocyte Maturation. [PDF]

Cell Prolif
Sun M, Zhao Y, Du Y, Fan Y, Wang K, Hu X.   +5 more
europepmc   +1 more source

iRGD-modified 3D exosomes delivered miR-99b-5p induces ferroptosis to inhibit colorectal cancer progression by regulating FGFR3/PI3K/AKt pathway. [PDF]

Stem Cell Res Ther
Li XH, Lian FW, Lv F, Luo XL, Hu BL, Zhang LT, Ning SF.   +6 more
europepmc   +1 more source

Evidence-based classification of genes implicated in skeletal disorders using the ClinGen curation framework. [PDF]

J Bone Miner Res
Webb RF, McCurry H, Girod A, Hughes M, Wilcox E, Patel M, Broeren EC, Tshering KC, DiStefano M, Botto LD, Burrage LC, Cormier-Daire V, Dong J, Ehmke N, Krakow D, Moosa S, Mortier G, Nagamani S, Pena L, Sanchez-Lara PA, Superti-Furga A, Unger S, Velasco D, Warman ML, Brown K, D'Cunha Burkardt D, Ferreira CR, ClinGen Skeletal Disorders Gene Curation Expert Panel.   +27 more
europepmc   +1 more source

Genomic Characterization of Urothelial Carcinoma and Sarcomatoid Carcinoma of the Upper Urinary Tract. [PDF]

Cancers (Basel)
Jaime-Casas S, Salgia NJ, Zugman M, Goes V, Moradi A, Shah K, Winayak R, Barragan-Carrillo R, Fann J, Zhang G, Mercier B, Castro DV, Dizman N, Hsu J, Chehrazi-Raffle A, Dorff T, Yip W, Pal SK, Tripathi A.   +18 more
europepmc   +1 more source

Identification of natural FGFR3 inhibitor for glioma using integrated computational and microRNA regulatory analysis. [PDF]

Sci Rep
Javaid S, Ali N, Shahid S, Majeed MN.
europepmc   +1 more source

Achondroplasia management in the era of targeted therapies: a meta-analysis of C-type natriuretic peptide analogs. [PDF]

J Endocr Soc
Kamrul-Hasan ABM, Uday S, Nagendra L, Dutta D, Bhattacharya S, Pappachan JM, Ashraf AP.   +6 more
europepmc   +1 more source

Linking shox/shox2 deficiency with fgfr3 gain-of-function and natriuretic peptides. [PDF]

Front Endocrinol (Lausanne)
Hoffmann S, Diebold S, Roeth R, Löwen A, Mellein S, Just S, Rappold GA.   +6 more
europepmc   +1 more source

Immune Phenotype in Urothelial Carcinoma: From Tumor Biology to Therapeutic Stratification. [PDF]

Cancers (Basel)
Toquero P, Castillo L, José LS, Alfranca A, Celada G, Velasco C, Figols L, Prada C, Pacheco M, Gajate P, Pernaut C, Martínez I, Colomer R, Romero-Laorden N.   +13 more
europepmc   +1 more source

FGF/FGFR signaling at the immune-stromal interface in autoimmune rheumatic diseases: from tissue remodeling to translational opportunities. [PDF]

Front Immunol
Zhong S, Meng X, Xiang Z, Qiu G, Sun S, Xie J, Xiao L.   +6 more
europepmc   +1 more source